Does Rifaximin Kill Good Bacteria?

Rifaximin is a prescription antibiotic used mainly for gut-related conditions, and yes, it does affect the bacteria living in your intestines. However, unlike broad-spectrum antibiotics that wipe out large portions of your gut microbiome, rifaximin is designed to stay mostly inside the digestive tract. This limits its impact on the rest of your body, but it still changes the balance of bacteria in your colon. The bigger question is whether that change is harmful or simply temporary, and the evidence suggests the effects are less disruptive than many other antibiotics.

How Does Rifaximin Work in the Gut?

Rifaximin is a semi-synthetic antibiotic derived from rifamycin. It works by binding to a bacterial enzyme called RNA polymerase, which stops bacteria from making the proteins they need to grow and multiply. This effectively kills susceptible bacteria or stops them from reproducing.

What makes rifaximin different is its chemical structure. It is poorly absorbed from the gastrointestinal tract. Less than 1% of an oral dose typically enters your bloodstream. This means nearly all of the drug stays in your gut, where it acts on the bacteria it encounters there. This targeted action is why doctors use it for conditions like travelers’ diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy, a complication of liver disease.

Because it stays local, it does not reach organs like the kidneys or liver in significant amounts. This is a major advantage over antibiotics like ciprofloxacin or amoxicillin, which circulate throughout the body and affect bacteria in the skin, lungs, and urinary tract.

Does Rifaximin Kill Good Bacteria?

Yes, rifaximin does kill some beneficial bacteria in the gut. No antibiotic currently available is selective enough to kill only harmful bacteria and leave all helpful ones untouched. Rifaximin reduces the overall bacterial load in the colon, and this includes species that are considered beneficial, such as Lactobacillus and Bifidobacterium.

But the degree of disruption matters. Studies have shown that rifaximin causes less dramatic shifts in the gut microbiome compared to other antibiotics. Research published in the journal Gut Microbes found that while rifaximin altered the composition of gut bacteria, the diversity of the microbiome largely recovered within a few weeks after treatment stopped. Diversity refers to the number of different bacterial species present, and higher diversity is generally associated with better gut health.

Another key point is that rifaximin does not appear to cause the same level of collateral damage as antibiotics that are absorbed systemically. For example, a course of ciprofloxacin can reduce gut bacterial diversity by as much as 25% and may take months to recover. Rifaximin’s effects are generally milder and more transient. The evidence suggests that while it does kill some good bacteria, the disruption is less severe and recovery is faster than with most other antibiotics.

What Happens to Your Gut Microbiome During Treatment?

During a typical course of rifaximin, which often lasts 10 to 14 days for IBS-D, the number of bacteria in your colon drops noticeably. You might experience changes in digestion during this time. Some people report bloating, gas, or changes in stool consistency. These symptoms are often temporary and reflect the shifting bacterial population.

Rifaximin also tends to alter the metabolic environment of the gut. Because fewer bacteria are present, there is less fermentation of undigested carbohydrates. This can reduce gas production, which is one reason the drug helps some people with bloating. But it can also change how your body absorbs certain nutrients, at least in the short term.

One notable effect is that rifaximin can reduce the presence of bacteria that produce short-chain fatty acids (SCFAs). These fatty acids, such as butyrate, are important for colon health. They serve as fuel for the cells lining your colon and help maintain the intestinal barrier. A temporary dip in SCFA production is not usually a problem for healthy people, but it is something researchers are studying in people with inflammatory bowel disease or other chronic gut conditions.

How Long Does the Microbiome Take to Recover?

The recovery timeline depends on several factors, including your baseline gut health, diet, and whether you take repeated courses of the drug. In general, most people see their gut bacterial populations return to near-normal levels within one to four weeks after stopping rifaximin.

This is faster than recovery from broad-spectrum antibiotics, which can take several months. The reason is likely related to the drug’s limited absorption and its narrower range of activity. Rifaximin does not completely sterilize the gut. Some bacterial groups are more resistant to it, and these can repopulate quickly once the drug is gone.

Your diet during and after treatment plays a role in recovery. Eating a variety of fiber-rich foods provides the substrates that beneficial bacteria need to regrow. Fermented foods like yogurt, kefir, and sauerkraut may also help reintroduce beneficial species. However, no large clinical trials have confirmed that specific foods or supplements speed up microbiome recovery after rifaximin specifically.

Does Rifaximin Cause Antibiotic Resistance?

Antibiotic resistance is a concern with any antimicrobial drug, and rifaximin is no exception. However, the risk profile is different because of how the drug is used.

Rifaximin is taken in short courses, usually no more than two weeks at a time. This limits the selective pressure on bacteria to develop resistance. Some research suggests that repeated courses of rifaximin may lead to reduced effectiveness over time, particularly in people with IBS-D who need multiple treatments.

Resistance to rifaximin is typically mediated by mutations in the bacterial gene that encodes RNA polymerase. These mutations can make bacteria less susceptible to the drug. However, because rifaximin reaches very high concentrations in the gut, it can often still kill bacteria even when they have some level of resistance. This is different from systemic antibiotics, where resistance can quickly render a drug useless.

There is also concern about cross-resistance. Rifaximin is related to rifampin, an antibiotic used to treat tuberculosis. Some studies have raised the question of whether rifaximin use could promote resistance to rifampin. The evidence is limited, and no large human trials have confirmed this link. But it remains a theoretical concern that researchers continue to monitor.

Who Should Be Cautious About Taking Rifaximin?

Most healthy adults tolerate rifaximin well. The most common side effects reported in clinical trials include nausea, headache, and flatulence. These are usually mild and resolve on their own.

People with severe liver disease need to be monitored carefully. While rifaximin is poorly absorbed, some amount does enter the bloodstream. In people with advanced cirrhosis, the liver’s ability to process the drug is reduced, which can lead to higher blood levels. Doctors often prescribe rifaximin for hepatic encephalopathy, but they may adjust the dose or monitor liver function during treatment.

Pregnant women should not take rifaximin unless a doctor determines it is clearly necessary. Animal studies have shown some effects on fetal development, but human data is limited. No clinical guidelines currently recommend routine use of rifaximin during pregnancy. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your healthcare provider.

Are There Alternatives to Rifaximin?

For people concerned about disrupting their gut microbiome, there are alternative approaches depending on the condition being treated.

For travelers’ diarrhea, bismuth subsalicylate (Pepto-Bismol) is an over-the-counter option that is not an antibiotic. It works by reducing inflammation and preventing bacteria from attaching to the intestinal lining. It is generally considered safe for short-term use, though it can turn your stool dark.

For IBS-D, other prescription options include eluxadoline, which reduces bowel contractions, and certain antispasmodic medications. Some doctors also recommend probiotics, though the evidence for their effectiveness in IBS is mixed. A review of clinical trials found that certain probiotic strains, particularly Bifidobacterium and some Lactobacillus combinations, may improve symptoms in some people. But results vary widely, and no single strain has been proven to work for everyone.

Dietary changes are another avenue. The low-FODMAP diet has shown benefit in clinical trials for reducing IBS symptoms. This diet restricts certain fermentable carbohydrates that feed gut bacteria and cause gas and bloating. It is not a cure, but it can be an effective management tool for some people.

Should You Take Probiotics with Rifaximin?

Some clinicians recommend taking probiotics alongside rifaximin to help maintain beneficial bacteria. This is a common practice, but the evidence supporting it is not strong.

One concern is that rifaximin may kill the probiotic bacteria you take, making them ineffective. Another is that taking probiotics during antibiotic treatment could theoretically delay the natural recovery of your native microbiome. Some research suggests that your original gut bacteria recover faster on their own than when probiotics are introduced during antibiotic treatment.

If you do choose to take probiotics, timing may matter. Taking them a few hours after your rifaximin dose may reduce the chance that the antibiotic kills them. However, no clinical guidelines currently exist for this specific combination. It is best to discuss this with your doctor rather than making the decision on your own.